Core Viewpoint - The article discusses the advancements and strategic significance of the bio-based platform compounds project by Saierke, focusing on the production of glucose dicarboxylic acid (GA) and 2,5-furandicarboxylic acid (FDCA), which are essential for the bio-based materials market and have the potential to replace petroleum-based products [4][10][19]. Group 1: Project Overview - The Saierke bio-based platform compound project has completed its first phase in Jiande, Zhejiang, with an investment of 700 million yuan, aiming for an annual production of 5,000 tons of FDCA and 50 tons of GA, expected to commence production by mid-2027 [4][6][19]. - The project will occupy an area of 60 acres and is designed to process 10,000 tons of glucose annually, with a projected annual sales revenue of 500 million yuan and tax revenue of 30 million yuan once fully operational [6][19]. Group 2: Technological Advantages - Saierke's choice of glucose over traditional fructose for production leads to a significant cost advantage, as crystallized glucose prices are only 1/3 to 1/2 of fructose prices, with global production capacity for glucose at 15 million tons per year [7][9]. - The production process achieves a purity of 99.997% for FDCA, with high yields of over 60% from glucose to GA and over 90% from GA to FDCA, while maintaining low physical losses and allowing for catalyst recycling [9][10]. Group 3: Market Potential - GA and FDCA are identified as two of the twelve most valuable platform compounds by the U.S. Department of Energy, each having independent and expansive market opportunities [10][12]. - The FDCA market is projected to transition from a specialty chemical to a bulk chemical market as production costs decrease to 10,000-20,000 yuan per ton by 2025, with Saierke targeting a cost of 1,000-1,500 yuan per ton at a scale of 500,000 tons [15][19]. Group 4: Industry Recognition and Future Plans - Saierke's project has gained industry recognition, winning the "Most Commercially Valuable Award" at the third DT New Leaf Awards, highlighting its significant commercialization potential [17]. - The company plans to establish a flagship factory with a production capacity of 5,000 tons per year by mid-2027, marking a critical step towards large-scale production and accelerating the shift from petroleum-based to bio-based materials [16][19].
投资7亿元!热门生物基聚合单体FDCA项目备案
DT新材料·2026-01-09 16:06